Literature DB >> 23907594

The sexual ethics of HPV vaccination for boys.

Jeroen Luyten1, Bart Engelen, Philippe Beutels.   

Abstract

Human papillomavirus (HPV) is one of the most common sexually transmitted infections. It is a leading cause of cervical cancer in women but the virus is increasingly being linked to several other cancers in men and women alike. Since the introduction of safe and effective but also expensive vaccines, many developed countries have implemented selective vaccination programs for girls. Some however argue that these programs should be expanded to include boys, since (1) HPV constitutes non-negligible health risks for boys as well and (2) protected boys will indirectly also protect girls. In this paper we approach this discussion from an ethical perspective. First, on which moral grounds can one justify not reimbursing vaccination for the male sex? We develop an ethical framework to evaluate selective vaccination programs and conclude that, in the case of HPV, efficiency needs to be balanced against non-stigmatization, non-discrimination and justice. Second, if vaccination programs were to be expanded to boys as well, do the latter then also have a moral duty to become immunized? Two arguments in favor of such a moral duty are well known in vaccination ethics: the duty not to harm others and to contribute to the public good of public health. However, we argue that these are not particularly convincing in the context of HPV. In contrast, we believe a third, more powerful but also more controversial argument is possible. In our view, the sexual mode of transmission of HPV constitutes an additional reason to believe that boys in fact may have a moral obligation to accept vaccination.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 23907594     DOI: 10.1007/s10730-013-9219-z

Source DB:  PubMed          Journal:  HEC Forum        ISSN: 0956-2737


  39 in total

1.  GAVI injects new life into HPV vaccine rollout.

Authors: 
Journal:  Lancet       Date:  2013-05-18       Impact factor: 79.321

Review 2.  Herpes simplex virus infections.

Authors:  R J Whitley; B Roizman
Journal:  Lancet       Date:  2001-05-12       Impact factor: 79.321

3.  Human papillomavirus vaccination in males: the state of the science.

Authors:  Luis F Barroso; Timothy Wilkin
Journal:  Curr Infect Dis Rep       Date:  2011-04       Impact factor: 3.725

4.  Do condoms prevent genital HPV infection, external genital warts, or cervical neoplasia? A meta-analysis.

Authors:  Lisa E Manhart; Laura A Koutsky
Journal:  Sex Transm Dis       Date:  2002-11       Impact factor: 2.830

5.  Beyond cervical cancer: burden of other HPV-related cancers among men and women.

Authors:  Anil K Chaturvedi
Journal:  J Adolesc Health       Date:  2010-04       Impact factor: 5.012

Review 6.  Vaccinating healthcare workers against influenza to protect the vulnerable--is it a good use of healthcare resources? A systematic review of the evidence and an economic evaluation.

Authors:  Amanda Burls; Rachel Jordan; Pelham Barton; Babatunde Olowokure; Beverley Wake; Esther Albon; Jeremy Hawker
Journal:  Vaccine       Date:  2006-01-09       Impact factor: 3.641

7.  Twenty years of selective hepatitis B vaccination: is hepatitis B declining among injecting drug users in England and Wales?

Authors:  A Judd; M Hickman; V D Hope; A J Sutton; G V Stimson; M E Ramsay; O N Gill; J V Parry
Journal:  J Viral Hepat       Date:  2007-08       Impact factor: 3.728

Review 8.  Chapter 9: Role of mucosal human papillomavirus in nongenital cancers.

Authors:  Maura L Gillison; Keerti V Shah
Journal:  J Natl Cancer Inst Monogr       Date:  2003

9.  The ethics of implementing human papillomavirus vaccination in developed countries.

Authors:  Erik Malmqvist; Gert Helgesson; Johannes Lehtinen; Kari Natunen; Matti Lehtinen
Journal:  Med Health Care Philos       Date:  2011-02

Review 10.  The biology and life-cycle of human papillomaviruses.

Authors:  John Doorbar; Wim Quint; Lawrence Banks; Ignacio G Bravo; Mark Stoler; Tom R Broker; Margaret A Stanley
Journal:  Vaccine       Date:  2012-11-20       Impact factor: 3.641

View more
  2 in total

Review 1.  Extending the Human Papillomavirus Vaccination Programme to Include Males in High-Income Countries: A Systematic Review of the Cost-Effectiveness Studies.

Authors:  Mohamed-Béchir Ben Hadj Yahia; Anaïs Jouin-Bortolotti; Benoît Dervaux
Journal:  Clin Drug Investig       Date:  2015-08       Impact factor: 2.859

2.  The Ethics of Vaccination Nudges in Pediatric Practice.

Authors:  Mark C Navin
Journal:  HEC Forum       Date:  2017-03
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.